Inhibition of Rho-kinase abrogates migration of human transitional cell carcinoma cells: Results of an in vitro study

Urologia Internationalis

Volumn 86, Issue 2, 2011, Pages 220-227

  Vom Dorp, Frank ^a,d   Sanders, Harald ^a   Boergermann, Christof ^a   Lümmen, Gerd ^b   Rübben, Herbert ^a   Jakobs, Karl H ^a   Schmidt, Martina ^a,c  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^b St Josef Hospital Troisdorf   (Germany)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Bladder cancer; Carcinoma cell migration; J82 cells; Rho kinase; T24 cells

Indexed keywords

ACTIN; CALCIUM ION; G PROTEIN COUPLED RECEPTOR; PHOSPHOLIPASE C; RHO FACTOR; RHO KINASE;

ACTIN FILAMENT; ARTICLE; BLADDER CARCINOGENESIS; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CANCER CELL CULTURE; CARCINOMA CELL; CELL LABELING; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN FUNCTION; STAINING; TRANSITIONAL CELL CARCINOMA;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ACTINS; AMIDES; BACTERIAL PROTEINS; BACTERIAL TOXINS; CALCIUM; CARCINOMA, TRANSITIONAL CELL; CELL LINE, TUMOR; CELL MOVEMENT; FURA-2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYSOPHOSPHOLIPIDS; MUTATION; PERTUSSIS TOXIN; PHALLOIDINE; PROTEIN KINASE INHIBITORS; PYRIDINES; RHO GTP-BINDING PROTEINS; RHO-ASSOCIATED KINASES; TYPE C PHOSPHOLIPASES;

EID: 79952991712     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321271     Document Type: Article

References (28)

1. von der Maase H, Sengelov L, Roberts JT, Ricci S, Dogliotti L, Oliver T, Moore MJ, Zimmermann A, Arning M: Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol 2005; 23: 4602-4608. (Pubitemid 46224062)
2. Sternberg CN, Yagoda A, Scher HI, Watson RC, Geller N, Herr HW, Morse MJ, Sogani PC, Vaughan ED, Bander N: Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer 1989; 64: 2448-2458. (Pubitemid 20014925)
3. Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Staehler M, Negrier S, Chevreau C, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Anderson S, Hofilena G, Shan M, Pena C, Lathia C, Bukowski RM: Sorafenib for treatment of renal cell carcinoma: final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. J Clin Oncol 2009; 27: 3312-3318.
4. Sablin MP, Negrier S, Ravaud A, Oudard S, Balleyguier C, Gautier J, Celier C, Medioni J, Escudier B: Sequential sorafenib and sunitinib for renal cell carcinoma. J Urol 2009; 182: 29-34; discussion 34.
5. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000; 100: 57-100.
6. Hall A: The cytoskeleton and cancer. Cancer Metastasis Rev 2009; 28: 5-14.
7. Rhee SG: Regulation of phosphoinositidespecific phospholipase C. Annu Rev Biochem 2001; 70: 281-312.
8. Berridge MJ, Lipp P, Bootman MD: The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 2000; 1: 11-21.
9. Oude Weernink PA, Jakobs KH, Schmidt M: Dynamic phospholipid signalling by G protein- coupled receptors. Biochim Biophys Acta 2007; 1768: 888-900. (Pubitemid 46452539)
10. Kundra V, Escobebo A, Kazlauskas A, Kim HK, Rhee SG, Williams LT, Zetter BR: Regulation of chemotaxis by the platelet-derived growth factor receptor-β Nat 1994; 367: 474-476. (Pubitemid 24046051)
11. Wu D, Huang CK, Jiang H: Roles of phospholipid signaling in chemoattractant-induced responses. J Cell Sci 2000; 113: 2935-2940.
12. rhoinduces rapid changes in cell morphology. J Cell Biol 1990; 111: 1001-1007.
13. Ridley AJ, Hall A: The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992; 70: 389-399.
14. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, Kaibuchi K: Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase) J BiolChem 1996; 271: 20246-20249. (Pubitemid 26281788)
15. Amano M, Chihara K, Kimura K, Fukata Y, Nakamura N, Matsuura Y, Kaibuchi K: Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 1997; 275: 1308-1311. (Pubitemid 27114159)
16. Han L, Stope MB, de Jesus ML, Wieland T, Rosskopf D, Mizuno K, Jakobs KH, Schmidt M: Direct stimulation of receptorcontrolled phospholipase D1 by phosphocofilin. EMBO J 2007; 26: 4189-4202. (Pubitemid 47525163)
17. Kamai T, Tsujii T, Arai K, Takagi K, Asami H, Ito Y, Oshima H: Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 2003; 9: 2632-2641. (Pubitemid 36842107)
18. Lümmen G, Virchow S, Rümenapp U, Schmidt M, Wieland T, Otto T, Rübben H, Jakobs KH: Identification of G protein-coupled receptors potently stimulating migration of human transitional cell carcinoma cells. Naunyn Schmiedebergs Arch Pharmacol 1997; 356: 769-776. (Pubitemid 27525076)
19. vom Dorp F, Sari AY, Sanders H, Keiper M, Oude Weernink PA, Jakobs KH, Schmidt M: Inhibition of phospholipase C-epsilon by Gi-coupled receptors. Cell Signal 2004; 16: 921-928. (Pubitemid 38638782)
20. Rümenapp U, Lümmen G, Virchow S, Hanske J, Meyer zu Heringdorf D, Jakobs KH: Sphingolipid receptor signaling and function in human bladder carcinoma cells: inhibition of LPA- but enhancement of thrombin-stimulated cell motility. Naunyn Schmiedebergs Arch Pharmacol 2000; 361: 1-11. (Pubitemid 30064647)
21. RUTT (Registry for urinary tract tumors): Harnwegstumorregister, Jahresbericht. Verh Dtsch Ges Urol 1985; 37: 665.
22. Moolenaar WH: Bioactive lysophospholipids and their G protein coupled receptors. Exp Cell Res 1999; 253: 230-238.
23. Spiegel S, Milstrien S: Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev 2003; 4: 397-407. (Pubitemid 36565571)
24. 2+ mobilization in SH-SY5Y neuroblastoma cells is independent of phosphoinositide sinalling, but dependent on sphingosine kinase activation. Biochem J 1999; 343: 45-45.
25. 2+ signalling by G protein-coupled receptors. EMBO J 1998; 17: 2830-2837.
26. Ridley AJ: Rho: themes and variations. Curr Biol 1996; 6: 1256-1264.
27. Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T, Narumiya S: Essential part for Rho-associated kinase in transcellular invasion of tumor cells. Nat Med 1999; 5: 221-225. (Pubitemid 29068531)
28. Chang HR, Huang HP, Kao YL, Chen SL, Wu SW, Hung TW, Lian JD, Wang CJ: The suppressive effect of rho kinase inhibitor, Y-27632, on oncogenic Ras/RhoA induced invasion/migration of human bladder cancer TSGH cells. Chem Biol Interact 2009; 183: 172-180.